You are here Home Product safety Shortages Medicine shortage alerts Vyvanse (lisdexamfetamine dimesilate) capsules shortage - resolved Published 1 May 2024 Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Takeda Pharmaceuticals Australia has notified us that all strengths of Vyvanse (lisdexamfetamine dimesilate) capsules are now available, as of 30 April 2024. Go to the Medicine Shortage Reports Database- external site for details. Topics Alert/Advisory Prescription medicines Shortages